Login / Signup
Paweł Marzęda
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 2
Top Topics
Basal Cell Carcinoma
Placebo Controlled
Phase Ii
Pain Management
Top Venues
Pharmacological reports : PR
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Paweł Marzęda
,
Paula Wróblewska-Łuczka
,
Magdalena Florek-Łuszczki
,
Agnieszka Góralczyk
,
Jarogniew J Luszczki
AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.
Pharmacological reports : PR
(2023)
Paweł Marzęda
,
Małgorzata Drozd
,
Paula Wróblewska-Łuczka
,
Jarogniew J Luszczki
Cannabinoids and their derivatives in struggle against melanoma.
Pharmacological reports : PR
73 (6) (2021)